|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02407 GAUSH MEDITECH
Nominal 
9.150 +0.080 (+0.882%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 107,783 | 249,038 | 234,422 | 164,486 | 130,001 |
| Net Cash from / (used in) Investing Activities | 18,549 | (167,654) | (136,040) | 79,835 | (998,022) |
| Net Cash from / (used in) Financing Activities | (303,094) | (189,936) | 3,078 | 72,843 | 856,356 |
| Increase / (Decrease) in Cash & Cash Equivalents | (176,762) | (108,552) | 101,460 | 317,164 | (11,665) |
| Cash & Cash Equivalents at beginning of period | 618,695 | 721,523 | 608,996 | 307,490 | 332,762 |
| Effect of Foreign Exchange Rate Changes | (20,495) | 5,724 | 11,067 | (15,658) | (13,607) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 421,438 | 618,695 | 721,523 | 608,996 | 307,490 |
| Remarks: | Real time quote last updated: 31/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 37,974 |
| %Change | 33.364% |
| EPS / (LPS) | RMB 0.260 |
| NBV Per Share (¥) | RMB 11.248 |